Prolonged azathioprine treatment reduces the need for surgery in early Crohn's disease
Prolonged azathioprine treatment reduces the need for surgery in early Crohn's disease
复制标题
长期硫唑嘌呤治疗可减少早期克罗恩病的手术需求。
DOI:
10.1111/jgh.14000
复制
发表时间:
2018-03-01
影响因子:
4.1
通讯作者:
Chen, Min-Hu
中科院分区:
文献类型:
--
作者:
Qiu, Yun;Chen, Bai-Li;Chen, Min-Hu
Background and AimWhether an early use of azathioprine (AZA) can alter the natural history of Crohn's disease (CD) remains debated. The aim of this study is to evaluate the impact of AZA on disease progression in a cohort of patients with early CD.MethodsThis longitudinal cohort study examined patients with early CD defined as disease duration 18months and no previous use of disease-modifying agents according to Paris definition. The primary outcome was the proportion of CD-related intestinal surgery. Cox regression analysis was performed to identify potential predictive factors of CD progression.ResultsOne-hundred and ninety patients with early CD were enrolled in the study. After a median follow-up of 57months (interquartile range, 31.3-76.2), 31 patients underwent abdominal surgeries, 48 patients were hospitalized, and 68 patients experienced clinical flares. The cumulative rate of remaining free of CD-related bowel surgery, hospitalization, and flare at 5years on AZA treatment was 0.65, 0.59, and 0.39, respectively. Three independent predictors of CD-related operations were identified: prior bowel resection (hazard ratio [HR], 9.23; 95% confidence interval [CI] 3.67-23.23), smoker (HR, 4.0; 95% CI 1.38-11.65), and hemoglobin 36months (HR, 0.04; 95% CI 0.01-0.15) was associated with reduced CD-related operations.ConclusionPrior bowel resection, smoking, and hemoglobin